MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Diabetes Care
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,044 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,044 works in the cohort · of 4,299,418page 16 of 21

Labels cover 1 of 1,044 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,044 of 1,044 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, Christian Laugesen, Chantal Mathieu, Athena Philis‐Tsimikas +1 more
2024· article· en· Diabetes Care· Medicine
machine prediction:candidate · noneconsensus · none
21
citations
affunlabeled
Islet Autoantibody Seroconversion in the DPT-1 Study
Kendra Vehik, Michael J. Haller, Craig A. Beam, Desmond Schatz, Diane K. Wherrett, Jay M. Sosenko +1 more
2011· article· en· Diabetes Care· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
21
citations
affunlabeled
Diabetes Research and Care Through the Ages
Bernard Zinman, Jay S. Skyler, Matthew C. Riddle, Ele Ferrannini
2017· article· en· Diabetes Care· Medicine
machine prediction:candidate · noneconsensus · none
20
citations
affunlabeled
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology–Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium–Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland
Thomas M. Caparrotta, Luke A. K. Blackbourn, Stuart J. McGurnaghan, John Chalmers, Robert S. Lindsay, Rory J. McCrimmon +8 more
2020· article· en· Diabetes Care· Medicine
machine prediction:candidate · noneconsensus · none
19
citations

How this was built: Screen · Findings · About